Miriam Merad, MD, PhD, Elected Fellow of the Accademia Nazionale dei Lincei
Miriam Merad, MD, PhD, has been elected a Fellow of the Accademia Nazionale dei Lincei, Italy’s historic and most prestigious scientific academy. Dr. Merad is one of 46 researchers worldwide chosen for induction in 2025. The new Fellows were formally recognized during a ceremony today in Rome at the opening of the Academy’s 2025–2026 academic year.
Dr. Merad is Dean for Translational Research and Therapeutic Innovation, Chair of the Department of Immunology and Immunotherapy, and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai. She is also Mount Sinai Professor in Cancer Immunology.
An internationally recognized physician-scientist, she has advanced fundamental understanding of the innate immune system, including pioneering discoveries about the development and function of macrophages and dendritic cells in cancer, inflammation, and tissue repair. Her work has illuminated new therapeutic strategies that are transforming immunology and oncology.
Dr. Merad’s election to the Lincei Fellowship caps a year of extraordinary honors:
- In May 2025, she was named a Chevalier de la Légion d’honneur (Knight of the Legion of Honor) by the French government for her pioneering contributions to science and medicine.
- Earlier in 2025, Dr. Merad received the Sjöberg Prize from the Royal Swedish Academy of Sciences for groundbreaking advances in cancer immunology.
Dr. Merad was elected to the National Academy of Sciences in 2020 and the National Academy of Medicine in 2023.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.
The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,700 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 560 postdoctoral research fellows.
Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek® and No. 7 in the U.S. on the magazine’s 2026 World’s Best Hospitals list and No. 3 in the world in its World’s Best Smart Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 9 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health grant funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Researchers Identify Immune Cell That Builds Cancer-Fighting Hubs Inside Tumors
Jul 16, 2026 View All Press Releases
Lung Cancer Rewires Immune Cells in the Bone Marrow to Weaken Body’s Defenses
Sep 10, 2025 View All Press Releases
Nano Drug Accelerates Diabetic Wound Healing in Mice
May 20, 2024 View All Press Releases
A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
Dec 06, 2023 View All Press Releases